The Effects of Statin Medications on Aerobic Exercise Capacity and Training Adaptations
Key Findings
The abstract's two claims: (1) the incidence of myopathy "increases dramatically" in statin users who also exercise, likely limiting the benefit of the medication; (2) new evidence indicates statin use can directly compromise aerobic exercise capacity — and the interactions of statins with training adaptations are only beginning to be understood.
The review's purpose is to summarise what is known and flag the gaps; it calls for practical solutions to reduce statin adverse effects associated with exercise.
Mechanism as covered in the review body (full text; not checked against the abstract): statins (HMG-CoA reductase inhibitors) lower mevalonate → reduced synthesis of CoQ10 (ubiquinone), dolichol and isoprenoids in skeletal muscle.
Statin-associated myopathy ranges from myalgia to rare rhabdomyolysis and is worsened by unaccustomed/eccentric exercise (full text; not checked against the abstract).
Evidence on training adaptations is conflicting: impaired adaptation in Mikus 2013 (REF-504), no harm reported in older adults by Panayiotou 2013 and Traustadottir 2008 (full text; not checked against the abstract).
Genetic modifier SLCO1B1 raises statin-myopathy risk (SEARCH Collaborative 2008; full text; not checked against the abstract).
Practical Application (not medical advice)
Murlasits & Radák 2014 (review): myopathy is markedly more common in statin users who exercise, and statins can directly reduce aerobic capacity and may blunt training adaptation ([REF-504]). An athlete on a statin should train with that in mind and talk to the prescribing physician rather than stop the drug.
Masters athlete on statins: report unexplained muscle pain/weakness/dark urine to a physician
Introduce new intense/eccentric loads gradually
Discuss checking vitamin D with a physician (deficiency reported to worsen statin myalgia — Gupta & Thompson 2011; full text; not checked against the abstract)
Limitations
Narrative review, not a meta-analysis; evidence selection non-systematic
Most mechanistic data are from rodents/cells, not trained masters athletes
How this entry was checked and changed
Content correction 2026-09-27
Type clarified: narrative review with a systematic search (2000-2013), no meta-analysis; level B+ kept.
Mechanistic detail (mevalonate/CoQ10), the conflicting-adaptation studies, SLCO1B1, Kokkinos 2013 and Gupta & Thompson 2011 marked as full-text content not in the abstract; the abstract's own two statements added as the first findings and as the lead Practical bullet.